Gallium 68 PSMA-11 (Ga 68 PSMA-11)is the First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer
U.S. Food and Drug Administration has approved Gallium 68 PSMA-11 (Ga 68…
Lynparza (olaparib), already licensed for breast and ovarian cancer,it's set to become the world's first precision medicine for prostate cancer.
A new clinical trial founds Lynparza (olaparib), the MSD and AstraZeneca PARP…